LINEAGE CELL THERAPEUTICS IN shareholders Q3 2023

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 105 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

LINEAGE CELL THERAPEUTICS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Squarepoint Ops LLC 24,631$29,0650.00%
OSAIC HOLDINGS, INC. 46,371$54,7150.00%
FMR LLC 1,444$1,7040.00%
DIMENSIONAL FUND ADVISORS LP 40,449$47,7300.00%
CENTRAL TRUST Co 29$350.00%
AMERICAN INTERNATIONAL GROUP, INC. 64,404$75,9970.00%
External links

This page lists LINEAGE CELL THERAPEUTICS IN's shareholders in Q3 2023. To view LINEAGE CELL THERAPEUTICS IN's shareholder history, click here.